|
| 37868034 | Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome prediction. | Cell Genom | 2023 |
| 35420683 | Patient-specific comorbidities as prognostic variables for survival in myelofibrosis. | Blood Adv | 2023 |
| 35979721 | Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes. | Haematologica | 2023 |
| 35190802 | Natural History and Characteristics of ERBB2-mutated Hormone Receptor-positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case-control Study from AACR Project GENIE. | Clin Cancer Res | 2022 |
| 35544069 | Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes. | JAMA Cardiol | 2022 |
| 34495297 | Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes. | JAMA Cardiol | 2021 |
| 33438044 | Correction to: Adduct annotation in liquid chromatography/high-resolution mass spectrometry to enhance compound identification. | Analytical and Bioanalytical Chemistry | 2021 |
| 33123762 | Adduct annotation in liquid chromatography/high-resolution mass spectrometry to enhance compound identification. | Analytical and Bioanalytical Chemistry | 2021 |
| 34581028 | MLL3 is a de novo cause of endocrine therapy resistance. | Cancer Medicine | 2021 |
| 34390291 | Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer Center. | Oncologist | 2021 |
| 33127913 | Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer. | Nat Commun | 2020 |
| 31747302 | Genomic Underpinnings of Tumor Behavior in <i>In Situ</i> and Early Lung Adenocarcinoma. | Am J Respir Crit Care Med | 2020 |
| 32984537 | INCIDENTAL PULMONARY METASTASES REVEALING SUBCENTIMETER PAPILLARY THYROID CARCINOMA. | AACE Clinical Case Reports | 2020 |
| 32697984 | RSK2 Maintains Adult Estrogen Homeostasis by Inhibiting ERK1/2-Mediated Degradation of Estrogen Receptor Alpha. | Cell Reports | 2020 |
| 30770368 | Correction: Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2<sup>+</sup> Breast Cancer. | Cancer Res | 2019 |
| 30965283 | Papillary thyroid carcinoma behavior: clues in the tumor microenvironment. | | 2019 |
| 30737216 | Correction: Drug-Resistant Brain Metastases: A Role for Pharmacology, Tumor Evolution, and Too-Late Therapy. | Cancer Discovery | 2019 |
| 30770492 | Correction: Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER<sup>+</sup> Breast Cancer. | Clin Cancer Res | 2019 |
| 30770490 | Correction: ER Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors. | Clinical Cancer Research | 2019 |
| 29453336 | Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis. | Scientific Reports | 2018 |
| 29310020 | Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia. | Leuk Res | 2018 |
| 29581135 | ER Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors. | Clinical Cancer Research | 2018 |
| 28039357 | Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade. | Mol Cancer Res | 2017 |
| 28751448 | Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER<sup>+</sup> Breast Cancer. | Clin Cancer Res | 2017 |
| 28794284 | Genomic profiling of ER<sup>+</sup> breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance. | Sci Transl Med | 2017 |
| 28396358 | Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2<sup>+</sup> Breast Cancer. | Cancer Res | 2017 |
| 28263985 | Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression. | PLoS Genet | 2017 |
| 28199054 | Optimization by infusion of multiple reaction monitoring transitions for sensitive quantification of peptides by liquid chromatography/mass spectrometry. | Rapid Communications in Mass Spectrometry | 2017 |
| 26574927 | C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype. | Cancer Biology and Therapy | 2016 |
| 27231203 | Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies. | Cancer Research | 2016 |
| 26249222 | Mitochondria sequence mapping strategies and practicability of mitochondria variant detection from exome and RNA sequencing data. | Brief Bioinform | 2016 |
| 25056374 | Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. | Clin Cancer Res | 2015 |
| 25492084 | Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. | Clin Cancer Res | 2015 |
| 25255959 | Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma. | Oral Oncol | 2015 |
| 25953087 | Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer. | Mol Cell Proteomics | 2015 |
| 26526693 | Drug-Resistant Brain Metastases: A Role for Pharmacology, Tumor Evolution, and Too-Late Therapy. | Cancer Discovery | 2015 |
| 26424146 | Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ. | BMC Cancer | 2015 |
| 25064609 | Desmoid-type fibromatosis-associated Gardner fibromas: prevalence and impact on local recurrence. | Cancer Letters | 2014 |
| 25322818 | Detection of internal exon deletion with exon Del. | BMC Bioinformatics | 2014 |
| 25392923 | Surgical resection margins in desmoid-type fibromatosis: a critical reassessment. | American Journal of Surgical Pathology | 2014 |
| 24310002 | Systematic mapping of occluded genes by cell fusion reveals prevalence and stability of cis-mediated silencing in somatic cells. | Genome Res | 2014 |
| 24327545 | SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on Both mRNA and protein levels. | Genes Chromosomes and Cancer | 2014 |
| 24656772 | SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer. | Cancer Cell | 2014 |
| 24560446 | Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounterâ¿¢ system. | Mol Oncol | 2014 |
| 23370767 | Expression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor/plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation. | Modern Pathology | 2013 |
| 23905624 | The genomic map of breast cancer: which roads lead to better targeted therapies? | Breast Cancer Research | 2013 |
| 23490885 | Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA. | Oral Oncol | 2013 |
| 23528864 | The different morphologies of urachal adenocarcinoma do not discriminate genomically by micro-RNA expression profiling. | Hum Pathol | 2013 |
| 23174932 | SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma. | Modern Pathology | 2013 |
| 23212519 | CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. | Blood | 2013 |